Notably, directly opposing the concept of FoxO1 being a tumor suppressor, ~ 46% of FoxO1 mutations involve sites close to T24, a phosphorylation site for negative regulation, making this site unrecognizable for Akt, and subsequently reducing FoxO1 nuclear export. The gene discussed is FOXO1; the disease is neoplasm.